Algatech Launches Fucovital: A Fucoxanthin From Microalgae
Thursday, June 7th, 2018 | 186 Views
Algatechnologies Limited, or Algatech, a fast-growing biotechnology company specialising in the commercial cultivation of microalgae, launches Fucovital—a patented, all-natural three percent fucoxanthin oleoresin produced and extracted from microalgae.
Fucovital’s unique composition is the first fucoxanthin granted New Dietary Ingredient Notification (NDIN) acknowledgement for dietary supplements from the FDA. The product will be launched in the US and Japan, and launches will follow in other regions successively.
Clinical trials demonstrate that fucoxanthin—a powerful antioxidant—can have significant benefits for preventing obesity-related metabolic syndrome such as impaired glucose management, inflammation, high triglyceride levels, and liver disorders.
Since year 2000, nearly 500 peer-reviewed articles have been published regarding fucoxanthin and its health benefits. The global fucoxanthin market is projected to grow at a compound annual growth rate of 3.2 percent through 2022, and is estimated to amount nearly 700 tons annually.
“Algatech will conduct series of studies to further substantiate the health benefits of fucoxanthin. This launch marks a significant milestone for Algatech and the microalgae industry.” says Hagai Stadler, chief executive officer of Algatech.
Fucoxanthin is traditionally extracted from harvested seaweed, which only contains approximately 0.01 percent fucoxanthin. This expensive and time-consuming process, coupled with prior inadequate extraction methods, limits the amount of fucoxanthin available in the market and increases cost significantly. Moreover, the old processes exposed product to contamination, relied on the harvest seasons of edible seaweed, and resulted in excessive waste.
Algatech’s microalgae fucoxanthin production overcomes these major challenges. The company identified a unique strain of algae, phaeodactylum tricornutum, that contains hundreds of times more concentrated fucoxanthin than seaweed.
It then successfully grew and standardised this strain in a closed and controlled cultivation system fully exposed to natural sunlight. Fucovital can be cultivated year-round and is not dependent on seasonal fluctuations.
“Fucovital is cultivated in a patented, eco-friendly, closed system, creating a pure, cost-effective new source of fucoxanthin with a consistent high quality,” says Omer Grundman, PhD, Algatech’s chief research and development (R&D) biologist and leader of R&D for FucoVItal.
“Our manufacturing process is completely sustainable, relying on power generated at an adjacent solar farm. The closed-cultivation system is unlike other available products, and has a minimal ecologic footprint,” Mr Grundman adds.
“Commercialization of new microalgae ingredients is something few companies have achieved. It requires diverse and accomplished research and skills, incorporating marine biology, biotechnology, and organic chemical engineering,” Mr Stadler continues.
He also commented: “We are proud to launch Fucovital, with its complete stability and boosted capacity. It is just one of series of microalgae ingredients Algatech is planning to launch in the next few years.”